bioRxiv/medRxiv TRiP Review Activity

81 Reviews — EMBO Press — Cancer Biology

Most recent first Previous |  Page 3: Articles 21-30  | Next

NLRP3 controls ATM activation in response to DNA damage.
PETRILLI, V., Bodnar-Wachtel, M., Huber, A.-L., Gorry, J., Hacot, S., Gerossier, L., Guey, B., Goutagny, N., Bartosch, B., Ballot, E., Ghiringhelli, F., Py, B., Coute, Y., Ballesta, A., Lantuejoul, S., Hall, J.
10.1101/2020.05.12.087015 — Posted: 2020-05-14 — Discussion: 2023-08-26  EMBO Press
ATR inhibition augments the efficacy of lurbinectedin in small cell lung cancer
Schultz, C. W., Zhang, Y., Elmeskini, R., Zimmermann, A., Fu, H., Murai, Y., Wangsa, D., Kumar, S., Takahashi, N., Atkinson, D., Saha, L. K., Lee, C.-F., Elenbaas, B., Desai, P., Sebastian, R., Ried, T., Aladjem, M., Zenke, F. T., Weaver, Z., Pommier, Y., Thomas, A.
10.1101/2022.12.16.520783 — Posted: 2022-12-19 — Discussion: 2023-08-02  EMBO Press
Highly multiplexed quantitative phosphosite assay for biology and preclinical studies
Keshishian, H., McDonald, E. R., Melanson, R., Porter, D. A., Mundth, F., Krug, K., Wallace, L., Forestier, D., Rabasha, B., Marlow, S. E., Jane-Valbuena, J., Todres, E., Specht, H., Golji, J., Kuhn, E., Burgess, M., MacMullan, M., Satpathy, S., Mani, D. R., Gillette, M., Clauser, K., Rejtar, T., Wang, K., Garraway, L. A., Sellers, W. R., Carr, S. A.
10.1101/2020.12.08.415281 — Posted: 2020-12-09 — Discussion: 2023-06-10  EMBO Press
RAS and PP2A activities converge on epigenetic gene regulation
Aakula, A., Sharma, M., Tabaro, F., Honkanen, H., Schapira, M., Arrowsmith, C., Nykter, M., Westermarck, J.
10.1101/2022.05.11.491459 — Posted: 2022-05-12 — Discussion: 2023-05-26  EMBO Press
ROR1 plays a critical role in pancreatic tumor-initiating cells with a partial EMT signature.
Yamazaki, M., Hino, S., Usuki, S., Miyazaki, Y., Oda, T., Nakao, M., Ito, T., Yamagata, K.
10.1101/2022.07.13.499868 — Posted: 2022-07-14 — Discussion: 2023-05-19  EMBO Press
β-catenin activity induces an RNA biosynthesis program promoting therapy resistance in T Acute Lymphoblastic Leukemia
Garcia-Hernandez, V., Arambilet, D., Guillen, Y., Lobo, T., Gekas, C., Vega-Garcia, N., Sentis, I., Trincado, J. L., Marquez-Lopez, I., Heyn, H., Camos, M., Espinosa, L., Bigas, A.
10.1101/2022.07.07.499249 — Posted: 2022-07-09 — Discussion: 2023-04-27  EMBO Press
An RNA-binding switch drives ribosome biogenesis and tumorigenesis downstream of RAS oncogene
Azman, M. S., Dodel, M., Capraro, F., Faraway, R., Dermit, M., Fan, W., Ule, J., Mardakheh, F. K.
10.1101/2021.12.16.472890 — Posted: 2021-12-16 — Discussion: 2023-04-25  EMBO Press
The eukaryotic translation initiation factor eIF4E reprogrammes the splicing machinery anddrives alternative splicing
Ghram, M., Morris, G., Culjkovic-Kraljacic, B., Gendron, P., Skrabanek, L., Revuelta, M. V., Cerchietti, L., Guzman, M., Borden, K.
10.1101/2021.12.07.471666 — Posted: 2021-12-09 — Discussion: 2023-03-15  EMBO Press
Uveal Melanoma: a miR-16 disease?
Quemener, A. M., Bachelot, L., Aubry, M., Avner, S., Leclerc, D., Salbert, G., Cabillic, F., Decaudin, D., Mari, B., Mouriaux, F., Galibert, M.-D., Gilot, D.
10.1101/2021.11.30.470499 — Posted: 2021-12-01 — Discussion: 2023-03-15  EMBO Press
Blockade of pro-fibrotic response mediated by the miR-143/-145 cluster prevents targeted therapy-induced phenotypic plasticity and resistance in melanoma
Diazzi, S., Baeri, A., Fassy, J., Lecacheur, M., Marin-Bejar, O., Girard, C., Lefevre, L., Lacoux, C., Irondelle, M., Mounier, C., Truchi, M., Couralet, M., Carminati, A., Berestjuk, I., Larbret, F., Vassaux, G., Marine, J.-C., Deckert, M., Mari, B., Tartare-Deckert, S.
10.1101/2021.07.02.450838 — Posted: 2021-07-03 — Discussion: 2023-03-15  EMBO Press

Evaluation Sources